| Patents for C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725) |
|---|
| 08/11/2005 | WO2005056510A3 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 08/11/2005 | WO2005000233A3 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 08/11/2005 | US20050176969 Novel fused ring compounds, and their use as cationic photoinitiators |
| 08/11/2005 | US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors |
| 08/11/2005 | US20050176619 N-[[1-[[2-(diethylamino)ethyl]amino]-7-methoxy-9-oxothioxanthen-4-yl]-methyl]formamide, or a pharmaceutically acceptable acid-addition salt thereof, and to the method of use thereof in the treatment of tumors and cancers. |
| 08/09/2005 | CA2327029C Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline |
| 08/04/2005 | US20050171151 Administering retinoic acid receptors (RAR) antagonist or an RAR inverse agonist for therapy of hyperlipidemia in mammal |
| 08/03/2005 | EP1558243A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 08/03/2005 | CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 08/03/2005 | CN1649830A Substituted aryl ketones |
| 08/03/2005 | CN1213040C Serine protese inhibitors |
| 07/28/2005 | WO2005068418A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 07/28/2005 | WO2005068415A1 Phenylalanine derivative |
| 07/28/2005 | WO2005032490A3 Cyclic diamines and derivatives as factor xa inhibitors |
| 07/28/2005 | US20050165259 Cannabinoids |
| 07/28/2005 | US20050165126 Thioxanthone derivatives, and their use as cationic photoinitiators |
| 07/28/2005 | US20050165095 preventing, treating or ameliorating retinoid poisoning, overdose by a retinoid; e.g. E-4-[3-(8,8-Dimethyl-5-p-tolyl-7,8-dihydro-naphthalen-2-yl)-3-hydroxyimino-propenyl]-benzoic acid (Compound 7a) and Z-4-[3-(8,8-dimethyl-5-p-tolyl-7,8-dihydro-naphthalen-2-yl)-3-hydroxyimino-propenyl]-benzoic Acid |
| 07/28/2005 | US20050164883 agronomically tolerable salts, isomers and enantiomers of those compounds, are suitable for use as herbicides |
| 07/26/2005 | US6921777 E.g., ethyl 3-methyl-5-(,5,8,8-tetra-methyl-5,6,7,8-tetra-hydronaphthalen-2 -ylselenyl)pent-2-en-4-ynoate; dermatological, rheumatic, respiratory, cardiovascular and ophthalmological uses as well as cosmetic uses |
| 07/21/2005 | WO2005066153A1 Tricyclic steroid hormone nuclear receptor modulators |
| 07/21/2005 | WO2005066116A1 Disubstituted chalcone oximes as selective agonists of rarϝ retinoid receptors |
| 07/21/2005 | WO2005066115A2 Disubstituted chalcone oximes having rarϝ retinoid receptor antagonist activity |
| 07/21/2005 | WO2004050609A8 Substituted ureas and carbamates |
| 07/21/2005 | US20050159449 Cannabinoids |
| 07/21/2005 | US20050159427 N-acylsulfonamide apoptosis promoters |
| 07/21/2005 | CA2552090A1 Disubstituted chalcone oximes as selective agonists of rar.gamma. retinoid receptors |
| 07/21/2005 | CA2551294A1 Disubstituted chalcone oximes having rary retinoid receptor antagonist activity |
| 07/20/2005 | EP1554265A2 Compounds, compositions and methods |
| 07/20/2005 | CN1211352C Cyclohexenone oxime ether metal salts |
| 07/19/2005 | US6919367 Substituted thioacetamides |
| 07/14/2005 | WO2005063729A1 3-(4-benzyloxyphenyl)propanoic acid derivatives |
| 07/14/2005 | WO2005063705A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 07/14/2005 | WO2005017185A3 HEPATOCYTE NUCLEAR FACTOR 4α MODULATOR COMPOUNDS |
| 07/14/2005 | US20050153958 Substituted aryl ketones |
| 07/14/2005 | CA2551610A1 3-(4-benzyloxyphenyl)propanoic acid derivatives |
| 07/13/2005 | CN1637052A Sulfonium salt photinitiators and use thereof |
| 07/13/2005 | CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders |
| 07/07/2005 | WO2005049593A3 N-acylsulfonamide apoptosis promoters |
| 07/07/2005 | US20050148777 (2R)-6-chloro-7-isobutyl-2-(trifluoromethyl)-2H-chromene-3-carboxylic acid; cyclooxygenase-2 mediated disorders |
| 07/07/2005 | US20050148590 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology |
| 06/30/2005 | WO2005058867A1 Benzothiophene-and thiochromene containing phenethanolamine derivatives for the treatment of respiratory disorders |
| 06/29/2005 | EP1545507A2 Activated checkpoint therapy and methods of use thereof |
| 06/23/2005 | WO2005057207A1 Trityl derivatives for enhancing mass spectrometry |
| 06/23/2005 | WO2005056510A2 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 06/23/2005 | WO2004024081A3 Acetyl 2-hydroxy-1,3 diaminoalkanes |
| 06/23/2005 | CA2545112A1 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 06/22/2005 | EP1542983A1 Heterodiamondoids |
| 06/22/2005 | EP1542964A2 Compounds for the treatment of alzheimer's disease |
| 06/22/2005 | CN1630649A Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid |
| 06/21/2005 | US6908722 Contains fluoroalkyl groups; for use in a chemically amplified radiation-sensitive resin mixture, gives high transparency, no bioaccumulation, high acidity of produced acid, high boiling point, short diffusion length |
| 06/16/2005 | WO2005053676A1 Use of pentadienoic acid derivatives for the treatment of hyperuricemia |
| 06/16/2005 | CA2547543A1 Use of pentadienoic acid derivatives for the treatment of hyperuricemia |
| 06/15/2005 | EP1539686A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 06/15/2005 | EP1317441B1 Method for producing a cyclohexenone oxime ether lithium salt |
| 06/15/2005 | EP1256576B1 Fused imidazolium derivatives |
| 06/14/2005 | US6905786 A thin layer contains aromatic tert-amine compound, sandwiched between a pair of electrodes; brightness |
| 06/14/2005 | CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
| 06/08/2005 | EP1538149A2 Sulfonium salts as photoinitiators |
| 06/07/2005 | US6903125 Tetrahydro-2H-thiopyran-4-carboxamide derivative |
| 06/02/2005 | WO2005049594A1 N-acylsulfonamide apoptosis promoters |
| 06/02/2005 | WO2005049593A2 N-acylsulfonamide apoptosis promoters |
| 06/02/2005 | US20050119257 Cyclic sulfone containing retroviral protease inhibitors |
| 06/01/2005 | EP1535919A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 06/01/2005 | EP1535612A1 Treatment for hyperuricemia |
| 06/01/2005 | EP1534658A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/01/2005 | EP1534276A2 Non-nucleoside reverse transcriptase inhibitors |
| 06/01/2005 | EP1416936B1 Thiopyrane-4-ones as dna protein kinase inhibitors |
| 06/01/2005 | CN1622943A Heterocycle-bearing onium salts |
| 05/31/2005 | US6900244 Controlling lipid, cholesterol metabolism; anticholesterol agents |
| 05/26/2005 | WO2005047236A1 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/19/2005 | WO2005028429A3 Haloalkyl containing compounds as cysteine protease inhibitors |
| 05/19/2005 | WO2005012220A9 Cycloalkylidene compounds as modulators of estrogen receptor |
| 05/19/2005 | US20050107367 2-(morpholin-4-yl)-6-phenyl-thiopyran-4-one; treating diseases which are retroviral mediated or ameliorated by the inhibition of DNA-PK |
| 05/17/2005 | US6894177 Viricides; human immunodeficiency virus |
| 05/17/2005 | US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus |
| 05/17/2005 | US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides |
| 05/10/2005 | US6890952 Administering cyclic substituted aminomethyl compounds for the preparation of a drug for the treatment of pain, urinary incotinence, itching, tinnitus aurium or diarrhea in a mammal |
| 05/10/2005 | US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1 |
| 05/05/2005 | US20050095531 Benzophenones substituted with one or more diarylsulfonium groups, used in photocurable adhesive, coating or sealant compositions, especially photocurable hot melt adhesives and a varnishs |
| 05/05/2005 | US20050095528 Sulfonium salt photinitiators and use thereof |
| 05/04/2005 | EP1446399B1 Piperazine derivatives having sst1 antagonistic activity |
| 04/28/2005 | WO2005037820A1 Process for the preparation of z-flupentixol |
| 04/28/2005 | US20050090526 3-Cyano-7-methoxy-4-(3-bromo-4,5-dimethoxyphenyl)-2-oxo-2H-chromene; 7-Amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-2-imino-2H-chromene; anticancer, antitumor agent |
| 04/27/2005 | EP1525268A1 Functional fluorescent dyes |
| 04/27/2005 | EP1144360B1 A method for the synthesis of compounds of formula 1 and derivatives thereof |
| 04/26/2005 | CA2213124C Benzoyl derivatives |
| 04/21/2005 | US20050085530 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| 04/21/2005 | US20050085511 Cyclic diamines and derivatives as factor Xa inhibitors |
| 04/14/2005 | WO2005032490A2 Cyclic diamines and derivatives as factor xa inhibitors |
| 04/14/2005 | US20050080119 Diaminopropionic acid derivatives |
| 04/13/2005 | CN1606552A Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| 04/13/2005 | CN1196692C Substituted benzopyran derivatives for the treatment of inflammation |
| 04/07/2005 | WO2004113289A3 Glycosidase inhibitors and methods of synthesizing same |
| 04/07/2005 | US20050075344 Melanocortin receptor agonists |
| 04/07/2005 | US20050075332 Tricyclic compounds with antiviral activity |
| 04/06/2005 | EP1519964A2 Polymeric photoinitiators |
| 04/05/2005 | US6875790 Viricides |
| 03/31/2005 | WO2005028429A2 Haloalkyl containing compounds as cysteine protease inhibitors |